BackFSD Pharma Overview

FSD Pharma Total Assets

Track FSD Pharma's total assets ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$15.25M
↓ 28.78% YoYΔ $-6.16M vs prior year quarter

Peer average

Loading

FSD Pharma Total Assets History

Loading

FSD Pharma vs. peers: Total Assets Comparison

Loading

FSD Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

FSD Pharma (HUGE) FAQ

FSD Pharma (HUGE) currently reports a total assets of $15M as of June 2024. That compares with $21M in the prior-year period — down 28.8% year over year. Use the charts on this page to explore FSD Pharma's total assets history and peer comparisons.

FSD Pharma's total assets decreased from $21M to $15M — a 28.8% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

FSD Pharma reported $15M in total assets as of June 2024. That compares with $21M in the prior-year period — down 28.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for FSD Pharma, and consider following HUGE for alerts when major investors trade the stock.

FSD Pharma is classified in the Healthcare sector. On total assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUGE with unrelated industries.